Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinryze in Aneurysmal Subarachnoid Hemorrhage
NCT06359782Phase 2Recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- Nov 2024
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of c1-esterase inhibitor in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Haaglanden Medical Centre. Started Nov 2024; status: recruiting.
02
Drugs
c1-esterase inhibitor
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT06359782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06359782.